NiCE Sets Webcast and Dial-In Details for Third-Quarter Results Call
NiCE will report third-quarter 2026 results on November 4 before the Nasdaq opens, followed by a management conference call.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
14 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
NiCE will report third-quarter 2026 results on November 4 before the Nasdaq opens, followed by a management conference call.
Halliburton reported third-quarter 2026 revenue of $5.7 billion and an adjusted operating margin of 12.8%. The company said it expects mid-single-digit revenue growth and operating margins of about 15% in 2027, an improvement of about 200 basis points.
Once Upon a Farm reported Q2 net sales growth of 42.3% year over year and raised its full-year 2026 net sales and adjusted EBITDA guidance.
On Thursday, Denali Therapeutics (NASDAQ: DNLI ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary Denali Therapeutics reported a succ
On Thursday, Natera (NASDAQ: NTRA ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Natera Inc. reported a record-breaking secon
Enovis (NYSE: ENOV ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary Enovis reported second quart
Lexicon Pharmaceuticals (NASDAQ: LXRX ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary Lexico
Planet Fitness (NYSE: PLNT ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. The full earnings call is available at Summary P
Haemonetics (NYSE: HAE ) released first-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary Haemonetics C
Regenxbio (NASDAQ: RGNX ) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summary Regenxbio reported strong prog
Prenetics Global (NASDAQ: PRE ) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is ava
Ares Management (NYSE: ARES ) held its second-quarter earnings conference call on Friday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. Access the full call at Summary Ares Management reported record q
Snowflake reported second-quarter product revenue of $1.49 billion, up 37% year over year, and raised FY27 product revenue guidance to $6.07 billion.
Minimed Group said first-quarter organic revenue grew 16% to $843 million and lifted fiscal 2027 organic revenue growth guidance to 10.5%, while reaffirming a 16% adjusted EBITDA margin target.